2021 Press Release Date Title 28/5/2021 Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans 28/5/2021 Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment 27/4/2021 Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit 3/2/2021 Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company
